Ledger.Open graph →
SEC Form D · filed September 23, 2021

Affect Therapeutics, Inc

Offering
$6.5M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Other
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jeff Rinehart · New York, NYDirectorKevin Ryan · New York, NYDirectorKristin Muhlner · Washington, Washington, D.C.Exec · DirectorJeff Deflavio · San Francisco, CADirectorJeff Rinehart · New York, NYDirectorJeff Deflavio · San Francisco, CADirectorKevin Ryan · New York, NYDirectorKristin Muhlner · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗